Analysis of some clinical and laboratory aspects of adolescent patients with thrombosis

Blood Coagulation and Fibrinolysis

Volumn 15, Issue 8, 2004, Pages 657-662

  Gurgey, Aytemiz ^a   Balta, Gunay ^a   Gumruk, Fatma ^a   Altay, Cigdem ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Adolescents; Factor V G1691A; Prothrombin G20210A; Thrombosis; Underlying disorders

Indexed keywords

BLOOD CLOTTING FACTOR 5; PROTHROMBIN;

ADOLESCENT; ADULT; ARTICLE; CANCER; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONGENITAL HEART DISEASE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HEART DISEASE; HUMAN; INFECTION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; PRIORITY JOURNAL; SCHOOL CHILD; THROMBOSIS;

ADOLESCENT; AGE FACTORS; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; FACTOR V; FEMALE; HEART DISEASES; HUMANS; INFANT; INFECTION; LIVER DISEASES; MALE; NEOPLASMS; PROTHROMBIN; RISK FACTORS; THROMBOSIS;

EID: 10044223480     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200412000-00005     Document Type: Article

References (23)

1. Richardson MW, Allen GA, Monahan PE. Thrombosis in children: current perspective and distinct challenges. Thromb Haemost 2002; 88:900-911.
2. Andrew M, David M, Adams M, Ali K, Anderson R, Bernard D, et al. Venous thromboembolic complications (VTE) in children: first analysis of the Canadian Registry of VTE. Blood 1994; 83:1251-1257.
3. Monagle P, Adams M, Mahoney M, Ali K, Barnard D, Bernstein M, et al. Outcome of pediatric thromboembolic disease: a report from the Canadian childhood thrombophilia registry. Pediatr Res 2000; 47:763-766.
4. Gurgey A, Mesci L, Renda Y, Olcay L, Kocak N, Erdem G. Factor V Q 506 mutation in children with thrombosis. Am J Hematol 1996; 53:37-39.
5. Gurgey A, Asian D. Outcome of noncatheter-related thrombosis in children: influence of underlying or coexisting factors. J Pediatr Hematol Oncol 2001; 23:159-164.
6. Revel-Vilk S, Chan A, Baumans M, Massicote P. Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease. J Thromb Haemost 2003; 1:915-921.
7. Tormene D, Simioni P, Prandoni P, Franz F, Zerbinati P, Tognin G, Girolami A. The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study. Blood 2002; 100:2403-2405.
8. Sass AE, Neufeld EJ. Risk factors for thromboembolism in teens: when should I test? Curr Opin Pediatr 2002; 14:370-378.
9. Bertina RM, Koeleman BPC, Koester T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64-67.
10. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88:3698-3703.
11. Gurgey A, Mesci L. The prevalence of Factor V Leiden (1691 G>A) mutation in Turkey. Turk J Pediatr 1997; 39:313-315.
12. Gurgey A, Hicsonmez G, Parlak H, Balta G, Celiker A. Prothrombin gene 20210 G-A mutation in Turkish patients with thrombosis. Am J Hematol 1998; 59:179-180.
13. Sutherland DE, Weitz IC, Liebman HA. Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment. Am J Hematol 2003; 72:43-52.
14. Brandtzaeg P, Sandset M, Joo GB, Ovstebo R, Abildgaard U, Kierulf R. The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic coagulation pathway inhibitor and fibrinopeptide A in systemic meningococcal disease. Thromb Res 1989; 55:459-470.
15. Smith OP, White B. Infectious purpura fulminans: diagnosis and treatment. Br J Haematol 1999; 104:202-207.
16. Gurgey A, Ozyurek E, Gumruk F, Celiker A, Ozkutlu S, Ozer S, Bilgic A. Thrombosis in children with cardiac pathology: frequency of factor V Leiden and Prothrombin G20210A mutations. Pediatr Cardiol 2003; 24:244-248.
17. Tripodi A. Levels of coagulation factors and venous thromboembolism. Hematologica 2003; 88:705-711.
18. Hagstrom JN, Walter J, Bluebond Langner R, Amatniek JC, Manno CS, High KA. Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease. J Pediatr 1998; 133:777-781.
19. Lawson SE, Butler D, Enayat MS, Williams MD. Congenital thrombophilia and thrombosis: a study in a single center. Arch Dis Child 1999; 81:176-178.
20. Junker R, Koch HG, Auberger K, Munchow N, Ehrenforth S, Nowak Gottl U. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol 1999; 19:2568-2572.
21. Akar N, Akar E, Deda G, Sipahi T, Orsal A. Factor V 1691 G-A, prothrombin 20210 G-A, and methylenetetrahydrofolate reductase 677 C-T variants in Turkish children with cerebral infarct. J Child Neurol 1999; 14:749-751.
22. Heller C, Heinecke A, Junker R, Knofler R, Kosch A, Kumik K, et al. Cerebral venous thrombosis in children: a multifactorial origin. Circulation 2003; 108:1362-1367.
23. Nowak-Gottl U, Junker R, Kreuz W, von Eckardstein A, Nohe N, Schobess R, Ehrenforth S. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood 2001; 97:858-862.